comparemela.com

Latest Breaking News On - Irlab therapeutics - Page 1 : comparemela.com

IRLAB has Completed a Successful End-of-Phase 2 Meeting with the FDA on the Design of the Phase III Program for Mesdopetam

GOTHENBURG, SWEDEN / ACCESSWIRE / February 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 22 February 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's .

Vastra gotalands lanGunnar olssonArvid carlssonMichaelj fox foundationNasdaq stockholmNobel laureateIntegrative screening processIrlab therapeuticsFood and drug administrationPhase iiaMeeting minutesArkinson 39s diseaseRlab therapeutics abPhase iiiPreclinical studiesNasdaq stockholm

IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program

GOTHENBURG, SWEDEN / ACCESSWIRE / January 3, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, January 3, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's .

Vastra gotalands lanGunnar olssonArvid carlssonPropharma groupMichaelj fox foundationNasdaq stockholmNew drug applicationBriefing bookNobel laureateIntegrative screening processIrlab therapeuticsS fdaGunnar olssonReatment for parkinson 39s diseasePhase iiiArkinson 39s disease

IRLAB s Phase IIb Study with Pirepemat Passes DSMB Safety Review with Unanimous Recommendation to Continue the Ongoing Phase IIb Study

17.07.2023 - GOTHENBURG, SWEDEN / ACCESSWIRE / July 17, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July 17, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson s .

Gunnar olssonArvid carlssonNobel laureateIntegrative screening processNasdaq stockholmIrlab therapeutics

IRLAB Therapeutics and the McQuade Center for Strategic Research and Development Enter into Agreement to Evaluate IRLAB s Neuropsychiatric Programs IRL757 and IRL942 Seite 1

16.05.2023 - ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLYGOTHENBURG, SWEDEN / ACCESSWIRE / May 16, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA); IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company . Seite 1

Vastra gotalands lanGunnar olssonMcquade centerDevelopment enterStrategic researchNasdaq stockholmChief executive officerIrlab therapeutics

IRLAB Changes CEO and Appoints New Chairman

20.02.2023 - GOTHENBURG, SWEDEN / ACCESSWIRE / February 20, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 13, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for . Seite 1

Vastra gotalands lanRichard godfreyGunnar olssonCarola lemneDepartment of medicine at karolinska institutetUniversity of gothenburgEuropean society of cardiologyAppoints new chairmanNasdaq stockholmVice chairmanVice presidentGastrointestinal therapy areasEuropean societyIrlab therapeutics

vimarsana © 2020. All Rights Reserved.